De Laine Kate M, Matthews Geoff, Grivell Rosalie M
Obstetrics and Gynaecology, Women's and Children's Hospital, North Adelaide, SA, Australia.
Aust N Z J Obstet Gynaecol. 2013 Aug;53(4):353-7. doi: 10.1111/ajo.12052. Epub 2013 Feb 25.
Vitamin D deficiency in pregnancy is associated with adverse events such as pre-eclampsia, primary caesarean section and vitamin D deficiency of the newborn. Vitamin D screening in pregnancy is not universal.
To evaluate the vitamin D status of pregnant women at our institution and assess the sensitivity of the current risk-based screening guideline.
A prospective audit of vitamin D levels of all women presenting for their first antenatal booking visit during 3 four-week periods (in 2009-2010) was conducted at the Women's and Children's Hospital, South Australia. The main outcome measure was 25-hydroxyvitamin D3 levels. Information was also collected on body mass index, self-reported ethnicity and whether or not vitamin D testing was indicated based on the hospital guidelines.
Four hundred and seventy-two women consented to inclusion in the audit. 67.4% (318/472) were 'low-risk' according to the hospital guidelines for vitamin D screening. 46.2% of these women and 78.6% of 'high-risk' women were vitamin D deficient (<60 nmol/L). Mean vitamin D levels were 62.7 ± 22.0 and 43.4 ± 26.3 nmol/L for low- and high-risk women, respectively. 54.9% (147/268) of women who were found to be vitamin D deficient were classified as 'low-risk' giving a sensitivity of 45% for the current risk-based screening guideline.
Based on current normal ranges for vitamin D, risk-based screening criteria for vitamin D deficiency in pregnancy fails to detect over half of vitamin D deficient women at our institution. Current South Australian guidelines should be amended in favour of universal screening of vitamin D for all pregnant patients at their booking visit.
孕期维生素D缺乏与子痫前期、剖宫产及新生儿维生素D缺乏等不良事件相关。孕期维生素D筛查尚未普及。
评估我院孕妇的维生素D状况,并评估当前基于风险的筛查指南的敏感性。
在南澳大利亚州妇女儿童医院对2009 - 2010年期间3个为期四周时段内首次进行产前检查的所有女性的维生素D水平进行前瞻性审计。主要观察指标为25 - 羟基维生素D3水平。还收集了体重指数、自我报告的种族信息以及根据医院指南是否需要进行维生素D检测的信息。
472名女性同意纳入审计。根据医院维生素D筛查指南,67.4%(318/472)为“低风险”。这些女性中有46.2%以及“高风险”女性中有78.6%维生素D缺乏(<60 nmol/L)。低风险和高风险女性的平均维生素D水平分别为62.7±22.0和43.4±26.3 nmol/L。被发现维生素D缺乏的女性中有54.9%(147/268)被归类为“低风险”,这表明当前基于风险的筛查指南的敏感性为45%。
基于目前维生素D的正常范围,孕期维生素D缺乏的基于风险的筛查标准未能在我院检测出超过一半的维生素D缺乏女性。南澳大利亚州目前的指南应修订,支持对所有孕妇在首次产前检查时进行普遍的维生素D筛查。